As the talk of reopening the economy begins its valid to ask whether this recent recovery in the markets is sustainable or are we setting up for another pullback when second quarter results are released. As we have noted several times the first quarter results being announced now aren’t giving a true picture of the coronavirus impact. Second quarter results will likely bring this picture into clearer focus.
Looking specifically at the companies in our wacky world consider the following;
After hitting a low of $191.16 back on March 18th Dexcom has recovered closing at $323.40 this . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.